BioSpace News Archive

Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced positive topline results from its recently completed Phase 2 clinical trial of vocacapsaicin (CA-008), a first-in-class, non-opioid therapeutic with FDA Breakthrough Therapy Designation.

Vonco Products LLC, an industry-leader in the contract manufacturing of liquid-tight medical devices and fluid bags, biohazard transport bags, and infection prevention PPE and equipment covers announced today that the company received certification of their Quality Management System to the requirements of ISO 13485:2016. This

Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39 th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section. About Seagen Seagen is a global biotechnology company that discovers, develops and commerci